GLAND Gland Pharma Ltd Product Launches Announcement 2024 - FDA Approval for Plerixafor Gland Pharma receives US FDA approval for Plerixafor Injection, 24 mg/1.2 mL (20 mg/mL), Single-Dose Vial, expects to launch in FY25..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Gland Pharma Ltd